BreastCheck and CervicalCheck Breast Screening Cervical Screening

Latest News

 

Mission Statement

The National Cancer Screening Service will develop and provide quality cancer screening programmes for people in Ireland.
Read more ...

Welcome to the National Cancer Screening Service Website

Implementing Ireland’s First National Population-based Colorectal Cancer Screening Programme
Download publication (PDF 115KB)

Guidelines for Quality Assurance in Cervical Screening
Download publication (PDF 335KB)

The National Cancer Screening Service was established by the Minister for Health and Children in January 2007. The establishment followed the launch of a Strategy for Cancer Control in Ireland 2006 (pdf file), which advocates a comprehensive cancer control policy programme in Ireland.

The Strategy examined prevention, screening, detection, treatment and management of cancer in Ireland in coming years and recommended the former Board of the National Cancer Screening Service.

The National Cancer Screening Service encompasses BreastCheck - The National Breast Screening Programme and CervicalCheck - The National Cervical Screening Programme.

The former Board of the NCSS also had a mandate that included a policy development and advisory role to the Minister for Health and Children relating to other potential cancer screening programmes.

As part of this mandate the NCSS established an Expert Group to review and explore the potential benefits of introducing a colorectal cancer screening programme. The Expert Group has submitted its recommendations to the Minister for Health and Children. Click here to download a copy of the NCSS recommendations for a colorectal cancer screening programme in Ireland.

At the request of the Minister for Health and Children the former Board of the NCSS undertook a review of the Human Papolloma Virus (HPV) vaccines and reviews of the rationale for the introduction of national population based bladder, prostate and lung cancer screening programmes.

The NCSS has also established an Expert Group on Hereditary Cancer Risk and has hosted the first ever interagency lung cancer research forum.

Further information on all these developments is available here.

Media Calls:
For press calls please call the Communications Team 01 865 9300